Cumberland Pharmaceuticals (CPIX) Invested Capital (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Invested Capital across 17 years of filings, most recently posting $51.8 million for Q2 2026.

• In Q2 2026, Invested Capital rose 57.38% year-over-year to $51.8 million; the TTM figure through Jun 2026 stood at $51.8 million (up 57.38% YoY), while the FY2025 annual figure was $56.9 million, up 50.51% from the prior year.
• Invested Capital came in at $51.8 million for Q2 2026 at Cumberland Pharmaceuticals, up from $26.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $60.8 million in Q1 2022 to a low of $26.5 million in Q1 2026.
• Average Invested Capital over 5 years is $46.8 million, with a median of $49.3 million recorded in 2023.
• Year-over-year, Invested Capital fell 22.4% in 2025 and jumped 57.38% in 2026.
• Over 5 years, Invested Capital stood at $52.2 million in 2022, then fell by 19.42% to $42.0 million in 2023, then retreated by 10.04% to $37.8 million in 2024, then jumped by 50.51% to $56.9 million in 2025, then fell by 8.99% to $51.8 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $51.8 million in Q2 2026, $26.5 million in Q1 2026, and $56.9 million in Q4 2025.